Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA 'Closely Monitoring' ZYN Nicotine Pouches
FDA 'Closely Monitoring' Zyn Nicotine Pouches After Marketing Approval
The Food and Drug Administration (FDA) announced on Thursday that it authorized the marketing of Zyn nicotine pouches but will be "closely monitoring youth use." Newsweek reached out to Zyn for comment.
FDA OKs sales of Zyn nicotine pouches, citing health benefits for adult smokers
Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris International’s Zyn to help adult smokers cut back or quit cigarettes.
FDA officially authorizes Zyn nicotine pouches for sale following health review
The U.S. Food and Drug Administration formally authorized Zyn nicotine pouches for sale after conducting an "extensive scientific review" about their safety.
FDA bans Red Dye No. 3
What will the FDA ban on red dye linked to cancer mean for business? Houston-area candy shops react.
Houston-area candy manufactures react to the U.S. Food and Drug Administration's ban on red dye linked to cancer.
What Foods Will Be Impacted by FDA’s Ban on Red Dye No. 3—And What Could Replace It
T he U.S. Food and Drug Administration (FDA) banned the use of Red Dye No. 3 in food and ingested drugs on Wednesday, more than three decades after the agency prohibited it from being used in cosmetics because of possible cancer risks.
FDA Bans Red Dye No. 3 From Food, Beverages and Ingested Drugs, Citing Link to Cancer in Lab Rats
After decades of debate, the Food and Drug Administration (FDA) has announced a ban on Red Dye No. 3, a synthetic food coloring that’s been linked to cancer in male lab rats. The decision comes after a petition filed in 2022 by advocacy groups,
AstraZeneca, Datroway and US FDA
US FDA approves AstraZeneca's drug for breast cancer
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of breast cancer, the health regulator said on Friday.
AstraZeneca’s Datroway approved in U.S. for HER2-negative breast cancer patients
DXd, has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor HR-positive, HER2-negative breast cancer who have received prior endocrine-based therapy and chemotherapy for unresectable or metastatic disease.
AstraZeneca Gets FDA Approval for Metastatic Breast Cancer Treatment Datroway
AstraZeneca said the U.S. Food and Drug Administration approved Datroway, a treatment for metastatic breast cancer developed in combination with Daiichi Sankyo. The Anglo-Swedish drugmaker on Friday said that the approval is for adult breast cancer patients who have received prior endocrine-based therapy and chemotherapy for unresectable or metastatic disease.
1d
RFK Jr. petitioned FDA in 2021 to revoke authorization of all COVID vaccines
Robert F. Kennedy Jr., who's nominated to become the next health secretary, asked the federal government to revoke its ...
1d
on MSN
Now that the FDA has banned red dye No. 3, what about more common food dyes?
Following the ban of red dye No. 3 in the United States, experts weigh in on the potential health risks of red dye No. 40, ...
1d
Yogurt Recall Update As FDA Sets Risk Level Over Plastic Contamination
Greek yogurt has been recalled because it may contain foreign objects, given the FDA's second-most severe risk level.
2d
Outgoing FDA Chief Flags Online Weight Loss Drug Dangers
Novo Nordisk's and Eli Lilly's weight loss drugs can cost over $1,000 for a month's supply, while compounded versions ...
1d
on MSN
FDA orders manufacturers to do a better job detecting bird flu in raw pet food
FDA wants pet food manufacturers to do a better job identifying possible signs of bird flu in raw foods such as uncooked meat ...
1h
The problem with pulse oximeters your doctor probably doesn’t know.
The common medical devices don’t work as well for Black patients. The FDA is now trying to do something about it.
Futurism
5h
FDA Working to Remove the Stuff in Cigarettes That Feels Good
A new FDA proposal would reduce the amount of feel-good nicotine in cigarettes to near-inconsequential levels.
8h
Keeping blood pressure under control is critical. There’s a new option for tough cases
About half of U.S. adults have high blood pressure and too few have it under control. Now some patients who've tried ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Trump
Zyn
COVID
nicotine pouches
Red dye
Feedback